Innovating Works
IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED DISEASES FONDAZIONE TELETHON ETS tramitó un HORIZON EUROPE: Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the cause of the disease and are required life-long. Thus, there i...
2023-04-14 | Financiado
OBGate: Creating an orthogonal gate to the brain INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un HORIZON EUROPE: Many impairing illnesses raging from metastatic cancers to neurodegenerative diseases affect the brain. Unfortunately, delivery of therapeutics to the brain is highly challenging due to the blood-brai...
2023-02-28 | Financiado
ISOBIOTICS: Isotopic Labeling of Biotherapeutics COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES tramitó un HORIZON EUROPE: Biological drugs such as peptides, proteins, oligonucleotides and analogs provide the patients with more efficacious and less toxic treatments and have lower attrition rates than chemical drugs since...
2022-07-14 | Financiado
ADC2GBM: Development of brain-permeable masked nanobody-drug conjugates to eliminate glioma stem cells INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un HORIZON EUROPE: Glioblastoma multiforme (GBM) is one of the most prevalent brain tumours and is currently incurable. Patients die from tumour recurrence after resection and chemotherapy. New treatments need to overco...
2022-05-02 | Financiado
CHINEQUALJUSTICE: Testing the Chinese Development Model under the Capabilities Approach: The Effects of Preferential Policies and Special Economic Zones on Inequality and Social Justice INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un H2020: The Peoples Republic of China (PRC) gradually transitions from an export-led and investment-driven economy towards a service-led and consumption-driven economy. These upcoming reforms will affect firm...
2020-07-01 | Financiado
LIGHT4LUNGS: Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un H2020: Light4lungs addresses the problem of antimicrobial resistance in the treatment of chronic lung infections, which are the leading cause of morbidity and mortality in patients with diseases such as cyst...
2019-12-01 | Financiado
TargetGBM: Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un H2020: Glioblastoma multiforme (GBM) is the most prevalent deadly brain tumour and is currently incurable. Patients die from recurrent tumours that grow from cells surviving the first round of treatment. Thi...
2019-07-01 | Financiado
EUROfusion: Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV tramitó un FP6: A Roadmap to the realization of fusion energy was adopted by the EFDA system at the end of 2012. The roadmap aims at achieving all the necessary know-how to start the construction of a demonstration p...
2014-01-01 | Financiado
NANO3BIO: NanoBioEngineering of BioInspired BioPolymers WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER tramitó un FP7: The Nano3Bio project convenes a consortium of world renowned experts from 8 EU universities, 1 large company, and 14 SME, to develop biotechnological production systems for nanoformulated chitosans. C...
2013-10-01 | Financiado
AIM4NP: Automated in-line Metrology for Nanoscale Production TECHNISCHE UNIVERSITEIT DELFT tramitó un FP7: Knowing the mechanical properties of workpieces and machine-tools also at the nanometer scale is an absolute necessity for an efficient nanoscale production. Current technologies are lacking the flexi...
2013-03-01 | Financiado
ML²: Design platform for economic production of multilayer Micro-Nano Bio Systems FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. tramitó un FP7: Microfluidics and lab-on-chip is an enabling technology with great growth potential. The life science industry has come to realise the trends and potential of miniaturisation which already have effect...
2012-09-01 | Financiado
RESTORATION: Resorbable Ceramic Biocomposites for Orthopaedic and Maxillofacial Applications UNIVERSITY OF NEWCASTLE UPON TYNE tramitó un FP7: Ceramic composite materials have for many years been considered to show great promise in the repair of musculoskeletal defects. The materials can mimic the structure of bone, and devices made from th...
2012-04-01 | Financiado
PLASMANURE: Novel plasma-catalyst reactor for the total conversion of the ammonia contained in pig manure into environmental neutral products ATEKNEA SOLUTIONS HUNGARY KFT tramitó un FP7: The EU trend towards concentration and intensification of livestock, in particular pig farming, has resulted in increased burdens related to waste management (increased water, soil and air ammonia pol...
2010-02-01 | Financiado
HELIMNET: Heavy Liquid Metal Network CONSIGLIO NAZIONALE DELLE RICERCHE tramitó un FP7: HeLiMnet is a project aimed at integrating the R&D efforts going on within and outside Europe, in different areas of investigation In particular it is intended to create a large and strong network for...
2010-01-20 | Financiado
RECATABI: Regeneration of Cardiac Tissue Assisted by Bioactive Implants INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un FP7: Heart failure is the end-stage of many cardiovascular diseases, but the leading cause is the presence of a large scar due acute to myocardial infarction. Current therapeutic treatments under developme...
2010-01-01 | Financiado
INTEG-RISK: Early Recognition, Monitoring and Integrated Management of Emerging, New Technology Related Risks EUROPEAN RISK RESILIENCE INSTITUTE EUVRI EWIV tramitó un FP7: INTeg-Risk is a large-scale integrating project aimed at improving the management of emerging risks in the innovative industry. This will be achieved by building a new risk management paradigm for eme...
2008-12-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.